Cite
HARVARD Citation
Massat, M. et al. (2021). Do anti‐IL‐6R blockers have a beneficial effect in the treatment of antibody‐mediated rejection resistant to standard therapy after kidney transplantation?. American journal of transplantation. 21 (4), pp. 1641-1649. [Online].